Keywords: Mylan, Patent settlement, Shionogi, CIMA Labs, Orapred, USA, Asthma

Mylan in patent settlement with Shionogi over Orapred ODT

Article | 11 October 2012

Print This

US generic drugs major Mylan (Nasdaq: MYL) has entered into a patent settlement with Japan’s Shionogi (TYO: 4507) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in